Canada markets closed

Algernon Pharmaceuticals Inc. (AGN.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2900+0.0150 (+5.45%)
At close: 3:59PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-08-31
2018-08-31
2017-08-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
1,908
605.734
93.816
354.474
Selling General and Administrative
4,336
1,308
854.739
1,097
Total Operating Expenses
6,244
1,914
948.555
1,452
Operating Income or Loss
-6,244
-1,914
-948.555
-1,452
Total Other Income/Expenses Net
250.381
11.619
-
-445.886
Income Before Tax
-5,976
-1,896
-937.594
-1,891
Income from Continuing Operations
-5,976
-1,896
-937.594
-1,891
Net Income
-5,976
-1,896
-937.594
-1,891
Net Income available to common shareholders
-5,976
-1,896
-937.594
-1,891
Basic EPS
-
-0.04
-0.02
-0.08
Diluted EPS
-
-0.04
-0.02
-0.08
Basic Average Shares
-
44,668
28,165
25,667
Diluted Average Shares
-
44,668
28,165
25,667
EBITDA
-
-1,887
-907.605
-1,324